Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Somatropin biosimilar - Biopartners/LG Chem

Drug Profile

Somatropin biosimilar - Biopartners/LG Chem

Alternative Names: Declage; Eutrophine; Eutropin; Eutropin Plus; LB-03002; rhGH; Somatropin Biopartners; Somatropina Biopartners; SR-rhGH; Valtropin

Latest Information Update: 17 Jul 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LG Life Sciences
  • Developer Biopartners GmbH; LG Chem; LG Life Sciences; Merck KGaA
  • Class Growth hormones; Hormonal replacements; Obesity therapies
  • Mechanism of Action Somatotropin receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Short stature; Somatotropin deficiency
  • Phase III Prader-Willi syndrome

Most Recent Events

  • 16 Sep 2019 LG Chem plans a bioavailability phase I trial in Healthy volunteers (NCT04085224) (SC)
  • 03 Aug 2017 Phase-II development for Short stature (In children, Treatment-naive) is ongoing in South Korea (SC, Controlled release)
  • 03 Aug 2017 Somatropin biosimilar is still in phase III trials for Prader-Willi syndrome (In children, In adults, In the elderly) in South Korea (SC, injection) (NCT02204163)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top